CIK 0001671927 · Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 01235 5430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Pao William Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 | ||
| 2025-05-15 | Herbst Roy Steven Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 | ||
| 2025-05-15 | Peterson Kristine Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 | ||
| 2025-05-15 | Kaul Siddharth Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 | ||
| 2025-05-15 | Bell John Irving Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 | ||
| 2025-05-15 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +26,198 | 26,198 | ||
| 2025-05-15 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +26,198 | 26,198 | ||
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +60,110 | $29.74 | $1.8M | 170,007 |
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +646,290 | $29.74 | $19.2M | 2,051,711 |
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +8,589 | $29.56 | $254K | 178,596 |
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +92,349 | $29.56 | $2.7M | 2,144,060 |
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Sale · 2.5% Convertible Senior Notes due 2030 | −0 | $10,533,376.12 | $0 | 0 |
| 2025-03-17 | BAKER BROS. ADVISORS LP Director | Sale · 2.5% Convertible Senior Notes due 2030 | −0 | $113,252,773.88 | $0 | 0 |
| 2025-02-25 | Pao William Director | Grant or award · Share Option (Right to Buy) | +24,443 | 24,443 | ||
| 2025-02-17 | St Leger Tina Amber CHIEF HR OFFICER | Grant or award · Employee Share Option (Right to Buy) | +23,212 | 23,212 | ||
| 2025-02-17 | St Leger Tina Amber CHIEF HR OFFICER | Grant or award · Restricted Share Units | +8,476 | 8,476 | ||
| 2025-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Employee Share Option (Right to Buy) | +14,802 | 14,802 | ||
| 2025-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Restricted Share Units | +5,405 | 5,405 | ||
| 2025-02-17 | Berman David M HEAD OF R&D | Grant or award · Employee Share Option (Right to Buy) | +129,518 | 129,518 | ||
| 2025-02-17 | Berman David M HEAD OF R&D | Grant or award · Restricted Share Units | +47,297 | 47,297 |
Page 4 of 6 · 118 trades